Budesonide in pharma franchise in Meghalaya

Budesonide in PCD pharma franchise in Bhubaneswar

Budesonide in top pharma company in Nagpur

Budesonide in pcd pharma supplier in Faridabad

Budesonide in phama franchise company in India
Budesonide in phama distributor in Raipur

Home/Products /budesonide-100mcg-inhaler

Buditerm 100 Inhaler

Composition : Budesonide (100mcg) Inhaler

Dosage Form : Inhaler

Packaging Type : carton with leaflet

Packaging : 120 Metered Dose

Price : ₹1/-

Buditerm 100 Inhaler, containing Budesonide (100mcg), is an effective inhalation therapy for managing and preventing asthma symptoms and controlling chronic obstructive pulmonary disease (COPD). Budesonide is a corticosteroid that reduces inflammation in the airways, minimizing swelling and mucus production. This action improves airflow, helping patients breathe more easily and preventing asthma attacks. It is a maintenance treatment designed for regular use and is not suitable for immediate relief of acute bronchospasms or asthma symptoms.

This inhaler is particularly suitable for mild to moderate cases of asthma and is often prescribed for children and adults requiring lower doses of corticosteroids. It can be used as part of a long-term management plan to achieve better respiratory health and reduce the risk of exacerbations. Regular use as directed by a healthcare provider helps improve the quality of life by minimizing the frequency and severity of symptoms.

Buditerm 100 Inhaler belongs to the Asthma and Pulmonary Respiratory therapy category. It provides a convenient and effective way to manage chronic respiratory conditions and prevent complications.

Read More

About the Product

Buditerm 100 Inhaler, containing Budesonide (100mcg), is an effective inhalation therapy for managing and preventing asthma symptoms and controlling chronic obstructive pulmonary disease (COPD). Budesonide is a corticosteroid that reduces inflammation in the airways, minimizing swelling and mucus production. This action improves airflow, helping patients breathe more easily and preventing asthma attacks. It is a maintenance treatment designed for regular use and is not suitable for immediate relief of acute bronchospasms or asthma symptoms.

This inhaler is particularly suitable for mild to moderate cases of asthma and is often prescribed for children and adults requiring lower doses of corticosteroids. It can be used as part of a long-term management plan to achieve better respiratory health and reduce the risk of exacerbations. Regular use as directed by a healthcare provider helps improve the quality of life by minimizing the frequency and severity of symptoms.

Buditerm 100 Inhaler belongs to the Asthma and Pulmonary Respiratory therapy category. It provides a convenient and effective way to manage chronic respiratory conditions and prevent complications.

Common side effects include dry mouth, throat irritation, and hoarseness. Rarely, it may cause oral thrush or adrenal suppression.

Buditerm 100 Inhaler is indicated for the management of asthma and the prevention of symptoms associated with chronic obstructive pulmonary disease (COPD).

Use regularly as prescribed by your doctor. Rinse your mouth after each use to reduce the risk of oral thrush. Not for emergency relief of asthma symptoms.

Store at room temperature (20°C to 25°C), away from direct sunlight, heat, and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation